Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hartmann

Showing results (191-200 of 251) with videos related to

Pageof 26
Sort By:
Archives of Toxicology|March 21, 2018
Induction of hemangiosarcoma in mice after chronic treatment with S1P-modulator siponimod and its lack of relevance to rat and humanFrancois Pognan, J Andreas Mahl, Maria Papoutsi, et al.
JAMA|April 24, 2014
Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trialMartin Ebinger, Benjamin Winter, Matthias Wendt, et al.
European Child & Adolescent Psychiatry|October 18, 2021
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessmentNatalia Szejko, Sally Robinson, Andreas Hartmann, et al.
Annals of Neurology|February 1, 2011
The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trialJean-Christophe Corvol, Cécilia Bonnet, Fanny Charbonnier-Beaupel, et al.
European Child & Adolescent Psychiatry|July 27, 2021
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventionsPer Andrén, Ewgeni Jakubovski, Tara L Murphy, et al.
Frontiers in Neurology|May 10, 2017
The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after StrokeLena Ulm, Sarah Hoffmann, Darius Nabavi, et al.
Plos Medicine|May 13, 2025
Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial)Stefan Halbherr, Stefanie Lerch, Sebastian Bellwald, et al.
Therapeutic Innovation & Regulatory Science|February 20, 2020
Shared Learnings on the New EMA First-in-Human and Early Clinical Trial Guideline: Proceedings From a DIAlogue Session at DIA Europe 2018Jan Willem van der Laan, Charles T Benson, Walter Janssens, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|November 10, 2021
Clinical Practice Patterns in Tic Disorders Among Movement Disorder Society MembersChristos Ganos, Harini Sarva, Lille Kurvits, et al.
Stroke|July 17, 2010
The ARUBA trial: current status, future hopesJ P Mohr, Alan J Moskowitz, Christian Stapf, et al.
Pageof 26

Showing results (191-200 of 251) with videos related to

Sort By:
Pageof 26
Archives of Toxicology|March 21, 2018
Induction of hemangiosarcoma in mice after chronic treatment with S1P-modulator siponimod and its lack of relevance to rat and humanFrancois Pognan, J Andreas Mahl, Maria Papoutsi, et al.
JAMA|April 24, 2014
Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trialMartin Ebinger, Benjamin Winter, Matthias Wendt, et al.
European Child & Adolescent Psychiatry|October 18, 2021
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessmentNatalia Szejko, Sally Robinson, Andreas Hartmann, et al.
Annals of Neurology|February 1, 2011
The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trialJean-Christophe Corvol, Cécilia Bonnet, Fanny Charbonnier-Beaupel, et al.
European Child & Adolescent Psychiatry|July 27, 2021
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventionsPer Andrén, Ewgeni Jakubovski, Tara L Murphy, et al.
Frontiers in Neurology|May 10, 2017
The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after StrokeLena Ulm, Sarah Hoffmann, Darius Nabavi, et al.
Plos Medicine|May 13, 2025
Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial)Stefan Halbherr, Stefanie Lerch, Sebastian Bellwald, et al.
Therapeutic Innovation & Regulatory Science|February 20, 2020
Shared Learnings on the New EMA First-in-Human and Early Clinical Trial Guideline: Proceedings From a DIAlogue Session at DIA Europe 2018Jan Willem van der Laan, Charles T Benson, Walter Janssens, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|November 10, 2021
Clinical Practice Patterns in Tic Disorders Among Movement Disorder Society MembersChristos Ganos, Harini Sarva, Lille Kurvits, et al.
Stroke|July 17, 2010
The ARUBA trial: current status, future hopesJ P Mohr, Alan J Moskowitz, Christian Stapf, et al.
Pageof 26